AML/MDS
Clinical trials for AML/MDS explained in plain language.
Never miss a new study
Get alerted when new AML/MDS trials appear
Sign up with your email to follow new studies for AML/MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at childhood leukemia in new trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD123-CAR T cells for children and young adults (up to age 21) with certain types of leukemia or related blood cancers that have come back or not responded to standard therapy. The treatment involves collecting the patient's own…
Matched conditions: AML/MDS
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug duo takes on tough blood cancers
Disease control Recruiting nowThis early-stage study tests a drug called danvatirsen, first by itself and then combined with venetoclax, in 38 adults with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The goal is to see if the treatment is safe and can shrink or contr…
Matched conditions: AML/MDS
Phase: PHASE1 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC